CARISMA THERAPEUTICS INC (CARM) Stock Analyst Earnings Estimates
NASDAQ:CARM - Nasdaq - US14216R1014 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40M 50.72% | 14.919M -62.70% | 19.632M 31.59% | 17.85M -9.08% | -100.00% | |||||||
| EBITDA YoY % growth | 13.63M -52.62% | -85.894M -730.18% | -58.825M 31.51% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 13.62M -52.51% | -88.731M -751.48% | -62.179M 29.92% | -17.34M 72.11% | -32.966M -90.12% | -33.296M -1.00% | -33.629M -1.00% | -33.965M -1.00% | -151.084M -344.82% | -152.832M -1.16% | -154.6M -1.16% | |
| Operating Margin | 34.05% | -594.75% | -316.72% | -97.14% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -2.00 -403.03% | -3.47 -73.50% | -1.46 57.93% | -0.66 54.94% | -0.67 -2.33% | -0.56 16.67% | -0.54 3.64% | -0.54 | -2.35 -333.96% | -2.05 12.61% | -1.77 13.43% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.09 66.00% | -0.10 67.10% | 0.00 100.00% |
| Revenue Q2Q % growth | 3.825M -58.41% | 3.825M 13.00% | 3.825M 4.71% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.682M 68.45% | -4.335M 67.02% | 197.88K 101.11% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.22 52.17% | -0.12 | -0.10 | -79.74% |
| Q4 2024 Q2Q % growth | -0.42 19.23% | -0.17 | -0.25 | -153.39% |
| Q3 2024 Q2Q % growth | -0.31 41.51% | -0.27 | -0.04 | -16.89% |
| Q2 2024 Q2Q % growth | -0.27 44.90% | -0.30 | 0.03 | 11.02% |
| Q1 2024 Q2Q % growth | -0.46 76.17% | -0.44 | -0.02 | -4.27% |
| Q4 2023 Q2Q % growth | -0.52 35.00% | -0.56 | 0.04 | 7.73% |
| Q3 2023 Q2Q % growth | -0.53 -126.50% | -0.58 | 0.05 | 8.80% |
| Q2 2023 Q2Q % growth | -0.49 84.69% | -0.61 | 0.12 | 19.49% |
| Q1 2023 Q2Q % growth | -1.93 | -0.91 | -1.02 | -112.60% |
| Q4 2022 Q2Q % growth | -0.80 -200.00% | -2.24 | 1.44 | 64.35% |
| Q3 2022 Q2Q % growth | 2.00 455.56% | -1.63 | 3.63 | 222.55% |
| Q2 2022 Q2Q % growth | -3.20 -2,033.33% | -2.65 | -0.55 | -20.66% |
| Q1 2022 Q2Q % growth | 0.00 100.00% | -2.04 | 2.04 | 100.00% |
| Q4 2021 Q2Q % growth | 0.80 827.27% | -1.50 | 2.30 | 153.48% |
| Q3 2021 Q2Q % growth | 0.36 289.47% | -0.07 | 0.43 | 604.20% |
| Q2 2021 Q2Q % growth | -0.15 37.50% | -0.06 | -0.09 | -132.21% |
| Q1 2021 Q2Q % growth | -0.35 -212.90% | -0.08 | -0.27 | -347.55% |
| Q4 2020 Q2Q % growth | -0.11 65.63% | -0.11 | 0.00 | -1.10% |
| Q3 2020 Q2Q % growth | -0.19 -46.15% | -0.08 | -0.11 | -132.84% |
| Q2 2020 Q2Q % growth | -0.24 64.18% | -0.10 | -0.14 | -152.11% |
| Q1 2020 Q2Q % growth | 0.31 487.50% | -0.09 | 0.40 | 450.67% |
| Q4 2019 Q2Q % growth | -0.32 | -0.08 | -0.24 | -276.49% |
| Q3 2019 Q2Q % growth | -0.13 | -0.12 | -0.01 | -10.83% |
| Q2 2019 Q2Q % growth | -0.67 | -0.11 | -0.56 | -511.04% |
| Q1 2019 Q2Q % growth | -0.08 | -0.09 | 0.01 | 10.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 3.729M 9.77% | 3.825M | -96K | -2.51% |
| Q4 2024 Q2Q % growth | 3.653M -14.83% | 5.528M | -1.875M | -33.92% |
| Q3 2024 Q2Q % growth | 3.385M -11.55% | 5.576M | -2.191M | -39.29% |
| Q2 2024 Q2Q % growth | 9.197M 158.34% | 4.004M | 5.193M | 129.70% |
| Q1 2024 Q2Q % growth | 3.397M 4.75% | 4.488M | -1.091M | -24.31% |
| Q4 2023 Q2Q % growth | 4.289M | 2.958M | 1.331M | 45.00% |
| Q3 2023 Q2Q % growth | 3.827M -90.43% | 1.224M | 2.603M | 212.66% |
| Q2 2023 Q2Q % growth | 3.56M | 1.088M | 2.472M | 227.21% |
| Q1 2023 Q2Q % growth | 3.243M | 3.806M | -563K | -14.79% |
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 543.997K | -543.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -50% | 0% | -29% |
| Revenue | 0% | -0.68% | 0% | 3.55% |